Updated Date:
27 Mar 2026
Product Detail:
ONPATTRO patisiran 10 mg/5 mL concentrated injection for infusion vial
Shortage Status:
Discontinued
AUST R:
380813
Availability:
Reduction in supply until supply is exhausted
Active Ingredient:
patisiran sodium
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Injection,concentrated
Supply Impact Dates
Management Action:
Patients are advised to consult their health professional to discuss alternative treatment options. An overseas-registered product has been approved for supply under Section 19A. The approval holder, ??Medison Pharma Australia Pty Ltd?, can be contacted for details on supply on 1800 566 020.